Fluke Biomedical acquires RaySafe | Fluke Biomedical
A message to our customers, partners, and distributors about Coronavirus (COVID-19)

Fluke Biomedical acquires RaySafe

EVERETT, WASHINGTON – Fluke Biomedical, the world’s leading manufacturer of biomedical test instruments, announced today the acquisition of RaySafe.

With this acquisition Fluke Biomedical adds industry leading quality assurance devices for diagnostic x-ray from RaySafe to its product offering. With an enhanced portfolio especially in the fields of diagnostic x-ray, real time dose monitoring systems for medical personnel, and patient dose tracking software solutions, the RaySafe product line will broaden Fluke Biomedical’s customer base and answer market demands with innovative and state-of-the-art solutions.

Fluke Biomedical’s goal with this acquisition is to provide healthcare providers, institutions and medical device manufacturers with a complete portfolio of test equipment. Both companies see the user-friendliness of their products, combined with advanced technology and maximum measurement accuracy as their major assets.

“The fact that our companies share a similar culture is an ideal basis for continuing our excellent relationships with our employees, customers and partners,” said Magnus Kristoferson, CEO of RaySafe. “We have experience in highly specialized markets all over the world, we know our business and we can now maximize our competencies. In the past, RaySafe has attracted the attention of the market not just for the functionality and measurement accuracy of its products, but also for the attractive design and intuitive user interface.”

Fluke Biomedical leads the world in the manufacture of biomedical test and simulation products, including electrical safety testers, patient simulators, performance analyzers, and fully integrated and automated performance testing and documentation systems. With worldwide sales and distribution channels, Fluke Biomedical anticipates growth through innovative design and creative solutions for its customers.

“The acquisition of RaySafe brings to Fluke Biomedical a strong team that has delivered leading innovation to the radiation test and safety markets,” said Eric Conley, General Manager of Fluke Biomedical. “The combination of RaySafe and Fluke Biomedical accelerates our ability to provide a broad portfolio of world class test equipment to our customers.”

Fresh perspectives and product enhancements, coupled with the commitment to customer satisfaction will remain the hallmark of both organizations.

About Fluke Biomedical -
Fluke Biomedical is the premiere, global provider of test and measurement equipment and services to the healthcare industry. We strive to be the best at delivering innovative solutions to improve quality of global health. We serve biomedical engineers, quality-assurance technicians, medical physicists, oncologists and radiation-safety professionals and are continually expanding our range of solutions to a broader range of health and safety professionals.

About RaySafe -
RaySafe offers a comprehensive solution for the X-ray room consisting of devices for quality assurance and service of diagnostic X-ray machines, real-time dose monitoring for medical staff and a patient dose tracking software. All products combine user-friendliness with state-of-the-art technology and are based on the company’s mission to help technicians, medical staff and patients avoid unnecessary radiation exposure. RaySafe was founded in 1994 in Billdal, Sweden, where the company headquarters is still located today. With offices in the US, UK, Germany, Singapore, India, Japan and China as well as with a closely connected sales network, RaySafe serves a global customer base that includes leading manufacturers of X-ray machines and university hospitals around the world. RaySafe is fully owned by Fluke Biomedical since 2014. For more information on RaySafe, visit www.raysafe.com.

For More Information -
Toll Free: (800) 850-4608
Phone: (440) 248-9300
Email: [email protected]